Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

Author: AbelAnna, BarnesMaria, ButtonKatherine, CampbellJohn, CarrollFran, GarlandAnne, HollinghurstSandra, JerromBill, KesslerDavid, KuykenWillem, LewisGlyn, MetcalfeChris, MorrisonJill, OdondiLang'o, Owen-SmithAmanda, PetersTim, RidgwayNicola, SherlockSofie, ThomasLaura, TurnerKatrina, TurnerNicholas, WilesNicola, WilliamsChris

Paper Details 
Original Abstract of the Article :
BACKGROUND: Only one-third of patients with depression respond fully to treatment with antidepressant medication. However, there is little robust evidence to guide the management of those whose symptoms are 'treatment resistant'. OBJECTIVE: The CoBalT trial examined the clinical effectiveness and c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781198/

データ提供:米国国立医学図書館(NLM)

Cognitive Behavioral Therapy as a Valuable Adjunct for Treatment-Resistant Depression

Depression is a prevalent and often debilitating condition. This study focuses on the effectiveness of cognitive behavioral therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for treatment-resistant depression (TRD) in primary care. The study involved a pragmatic, multicenter individually randomized controlled trial, where participants were randomly assigned to either usual care or CBT in addition to usual care. The primary outcome was a significant reduction in depressive symptoms at 6 months, and the study found that the CBT group demonstrated a substantial improvement in response rates compared to the usual care group. Furthermore, these positive effects, including remission of symptoms, were sustained over a 12-month period. The intervention was deemed cost-effective, suggesting that CBT could be a valuable tool in managing TRD.

The Promise of CBT for Depression

This study provides compelling evidence for the effectiveness of CBT as an adjunct to usual care for TRD. The findings suggest that CBT could be a valuable tool for primary care providers in managing patients with TRD, potentially leading to improved outcomes and reduced healthcare costs. The study's results also underscore the importance of considering non-pharmacological interventions for depression, as CBT has proven to be effective in addressing the underlying cognitive and behavioral patterns that contribute to depression.

Empowering Patients with CBT

This research provides a glimmer of hope for individuals struggling with TRD. CBT can provide patients with valuable tools and strategies to manage their depression, empowering them to take an active role in their recovery. It's essential to remember that treatment for TRD is often a journey, and finding the right combination of therapies can be crucial. This research suggests that CBT could be an important part of this journey, potentially leading to long-term improvements in mental health.

Dr. Camel's Conclusion

This study is a testament to the power of the mind in overcoming depression. The researchers have shown that CBT, when used in conjunction with medication, can be a powerful tool for combating TRD. Like a desert traveler finding a spring of water, CBT offers a refreshing and effective approach to mental health.

Date :
  1. Date Completed 2015-01-12
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

24824481

DOI: Digital Object Identifier

PMC4781198

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.